D&D Pharmateck is showing a consolidation pattern as profit-taking selling pressure emerged following its recent short-term stock price gains.

During the morning session on the 10th, D&D Pharmatech traded at 85,900 won, down 700 won (0.81%) from the previous trading day. The intraday high reached 92,500 won and the low was 82,300 won, continuing to fluctuate.

With selling pressure persisting from the early hours of trading, the stock price is moving at a slightly lower level compared to the previous day. The market expects that D&D Pharmatech's future stock price movement will be influenced by the progress of its clinical development, news related to technology transfers, and changes in bio investment sentiment.

In particular, given the nature of the biotech sector, stock price volatility may increase depending on clinical results and corporate disclosures. Analysts advise that investors should monitor relevant disclosures alongside market trends.

On the same day, looking at the U.S. stock market closing, both the Dow and Nasdaq rose, with the Nasdaq's gains driven largely by strong performances from semiconductor stocks. Attention is now focused on how the ongoing market trends will serve as a variable for the domestic biotech sector.

[※ This article was written using AI. It is based on publicly available intraday market prices, and stock prices may fluctuate in real time. Investment decisions should be made carefully at the investor's own responsibility after directly verifying the latest disclosures and market prices.]